You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 158 A novel, highly accurate liquid biopsy-based glycoproteomic predictor of checkpoint inhibitor treatment benefit in advanced non-small cell lung cancer

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
158 A novel, highly accurate liquid biopsy-based glycoproteomic predictor of checkpoint inhibitor treatment benefit in advanced non-small cell lung cancer
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2024

AbstractFullPdf
Nov 2022206015
Dec 2022164012
Jan 20234606
Feb 2023110010
Mar 20237003
Apr 20236204
May 202311409
Jun 20236604
Jul 202334010
Aug 20234807
Sep 20233004
Oct 20238609
Nov 20234004
Dec 20233803
Jan 20243003
Feb 20243004
Mar 20242805
Total12020112